Comerica Bank’s Procept Biorobotics PRCT Stock Holding History

Comerica Bank’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$553K	Sell	17,575 -368,841	-95%	-$12.2M	﹤0.01%	1813
2025 Q3	$13.8M	Buy	386,416 +17,832	+5%	+$814K	0.05%	343
2025 Q2	$21.2M	Buy	368,584 +132,781	+56%	+$7.51M	0.08%	239
2025 Q1	$13.7M	Buy	235,803 +114,645	+95%	+$7.83M	0.06%	319
2024 Q4	$9.76M	Sell	121,158 -25,142	-17%	-$2.15M	0.04%	422
2024 Q3	$11.7M	Buy	+146,300	New	+$10.4M	0.05%	372
2023 Q4	–	Sell	-263	Closed	-$8.63K	–	3809
2023 Q3	$8.63K	Buy	+263	New	+$8.97K	﹤0.01%	3233

Other funds holding PRCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Comerica Bank's PRCT Position: Q4 2025 in Review

Comerica Bank reduced its Procept Biorobotics (PRCT) stake by 95% in Q4 2025, selling an estimated $12.2M and leaving 17,575 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

Comerica Bank first reported a position in PRCT in Q3 2023 and has held it in 7 quarters since. The position peaked at $21.2M in Q2 2025. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

Comerica Bank held 17,575 shares of Procept Biorobotics worth $553K as of Q4 2025.
Comerica Bank sold 368,841 Procept Biorobotics shares in Q4 2025, an estimated $12.2M.
Procept Biorobotics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1813 holding.
Comerica Bank first reported a position in Procept Biorobotics in Q3 2023 and has held it in 7 quarters since.
Comerica Bank's Procept Biorobotics position peaked at $21.2M in Q2 2025.
263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.